PAVM - PAVmed Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 534.85M
Enterprise Value 336.55M
Trailing P/E N/A
Forward P/E 1-3.68
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.96

Trading Information

Stock Price History

Beta (3Y Monthly) 0.55
52-Week Change 3-24.01%
S&P500 52-Week Change 32.99%
52 Week High 31.4000
52 Week Low 30.8600
50-Day Moving Average 30.9886
200-Day Moving Average 31.0941

Share Statistics

Avg Vol (3 month) 3204.51k
Avg Vol (10 day) 3164.41k
Shares Outstanding 535.06M
Float 22.69M
% Held by Insiders 133.64%
% Held by Institutions 116.00%
Shares Short (Aug 15, 2019) 4769.19k
Short Ratio (Aug 15, 2019) 45.67
Short % of Float (Aug 15, 2019) 43.73%
Short % of Shares Outstanding (Aug 15, 2019) 42.19%
Shares Short (prior month Jul 15, 2019) 41.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-84.33%
Return on Equity (ttm)-760.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.33M
Net Income Avi to Common (ttm)-17.47M
Diluted EPS (ttm)-0.6470
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.91M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)6.79M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.78
Book Value Per Share (mrq)-0.11

Cash Flow Statement

Operating Cash Flow (ttm)-11.27M
Levered Free Cash Flow (ttm)-5.95M